IR-MED Reports 92% Efficacy for PressureSafe™ in Early, Non-Invasive, Skin Color Agnostic Detection of Pressure Injuries
Incidence of pressure injuries reduced by 50% during the study period As a decision support device, PressureSafe, can support early detection of pressure injuries, potentially setting a new standard of care to address a healthcare challenge that costs $26.8 billion annually in the U.S. alone Data reported at NPIAP 2024 Annual Conference to key thought […]
IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16
Final results to be reported from a study conducted at two medical centers owned by Clalit, the world’s second largest health maintenance organization (HMO) and the largest in Israel PressureSafe, for the detection of pressure injuries, addresses a healthcare challenge that costs $26.8 billion and causes 60,000 deaths annually in the U.S. alone Rosh Pina, […]
AI-Driven Healthcare Revolution
Published at Journal Asian Hospital & Healthcare Managementissue 63 , February 2024 Printer Friendly Transforming Pressure Injury Detection Pressure injuries are a global healthcare concern leading to significant suffering and healthcare costs. Recent advancements in biotechnology and AI have emerged as promising tools in early pressure injury detection and prevention. AI, combined with non-invasive Infra […]
IR-MED Awarded Most Innovative Non-Invasive Diagnostics Technology Developer 2023 by Corporate Vision Magazine
PressureSafe, for the early detection of pressure injuries, addresses a healthcare challenge that costs $26.8 billion and causes 60,000 deaths annually in the U.S. alone Non-invasive device to augment visual inspection found to be more than 90% accurate in detecting pressure injuries Rosh Pina, Israel, Dec. 21, 2023 (GLOBE NEWSWIRE) — IR-MED Inc., (“IR-MED” or […]
IR-MED Granted Patent in Israel for its AI-Driven Platform Technology: Non-Invasive Analysis of Subcutaneous Tissue
The Granted patent covers IR-MED’s PressureSafe™ decision support device for the early detection of pressure injuries addressing a healthcare burden that amounts to $26.8 billion in the U.S. annually with a non-invasive device that offers more than 90% accuracy Rosh Pina, Israel, Dec. 07, 2023 (GLOBE NEWSWIRE) — IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of […]
IR-Med to present at National Pressure Injury Advisory Panel 2023
The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) — “IR-MED” or the “Company”) (OTCQB:IRME), will be presenting its proprietary technology that is being designed to detect early-stage Pressure Injuries (PI) at the Annual Conference of the National Pressure […]
IR-Med appoints Dr. Lynn Eschenbacher to its advisory board as Company advances towards its launch of PressureSafe wound care device
– Innovative executive driving positive outcomes and profitability, Dr. Eschenbacher is focused on addressing healthcare access and equity – Through early, non-invasive detection of pressure injuries, PressureSafe is poised to save billions in acute care costs and reduce patient deaths from pressure wounds Rosh Pina, Israel, June 07, 2023 (GLOBE NEWSWIRE) — IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive AI-driven […]
IR-Med honors Juneteenth with commitment to healthcare equality: PressureSafe device sees beneath the skin to address inequality in pressure injury
-Early detection of pressure injuries can be challenging for minority populations due to the current method of visual inspection -Patients with dark skin tones suffered more than twice as much as those with lighter skin, evidencing a major health inequality in the U.S. -Dr. Dalton, a visionary healthcare thought leader and hall of fame CEO, is supporting IR-Med in analyzing the benefits of the […]
